The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab
Author:
Affiliation:
1. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/56/11/56_56.8235/_pdf
Reference13 articles.
1. 1. Jennette J, Falk R, Bacon P, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013.
2. 2. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310-317, 2009.
3. 3. Pego PM, Camara IA, Andrade JP, Costa JM. Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa. Auto Immun Highlights 4: 95-99, 2013.
4. 4. Seri Y, Shoda H, Hanata N, et al. A case of refractory polyarteritis nodosa successfully treated with rituximab. Mod Rheumatol 1-3, 2015 (Epub ahead of print).
5. 5. Campanilho-Marques R, Ramos F, Canhao H, Fonseca JE. Remission induced by infliximab in a childhood polyarteritis nodosa refractory to conventional immunosuppression and rituximab. Joint Bone Spine 81: 277-278, 2014.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Polyarteritis nodosa complicated by renal aneurysm and intestinal perforation: A case report;Medicine;2024-08-23
2. Steroid sparing in vasculitis: Myth or reality?;Best Practice & Research Clinical Rheumatology;2023-03
3. Efficacy of rituximab in refractory polyarteritis nodosa: a case report;Pan African Medical Journal;2023
4. Off-Label Uses of Rituximab in Dermatology;Current Dermatology Reports;2022-10-06
5. Cutaneous polyarteritis nodosa: An atypical simulator. Report of 3 cases and a narrative review of the literature;Revista Colombiana de Reumatología (English Edition);2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3